2m 2m 2m 2m 2m 2m 2m
Kura Oncology (KURA)
NASDAQ
$10.30-$0.06 (-0.58%)
Price as of Jun 23, 2026 6:55 PM EDT- $919.7MMarket Cap
- 76.49%1-Year Change
- BiotechnologyIndustry
Kura Oncology (KURA)
$10.30-$0.06 (-0.58%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 2.1M -96.04% | 53.9M N/A | N/A N/A | N/A N/A | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 2.1M -96.04% | 53.9M N/A | 0 N/A | 0 N/A | |
Sales and Marketing Expense | 120.0M N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -251.1M +47.72% | -170.0M +47.50% | -115.2M +24.16% | -92.8M +9.55% | |
Depreciation and Amortization Expense | 1.0M +21.70% | 848,000 -0.12% | 849,000 +11.86% | 759,000 +36.02% | |
Total Operating Expenses | 371.1M +50.20% | 247.1M +49.02% | 165.8M +18.55% | 139.9M +6.56% | |
Operating Profit | -303.6M +57.16% | -193.2M +26.58% | -152.6M +12.36% | -135.8M +4.12% | |
Interest Income | 26.8M +17.18% | 22.8M +55.20% | 14.7M +246.07% | 4.3M +252.74% | |
Interest Expense | N/A N/A | -1.6M +4.52% | -1.5M +576.42% | -229,000 -44.69% | |
Interest Income and Expense and Net | 26.8M +26.11% | 21.2M +61.16% | 13.2M +227.28% | 4.0M +408.21% | |
Total Nonoperating Income and Expense | 25.3M +18.99% | 21.2M +61.16% | 13.2M +227.28% | 4.0M +408.21% | |
Income before Taxes | -278.4M +61.88% | -172.0M +12.67% | -152.6M +12.36% | -135.8M +4.12% | |
Income Taxes | 297,000 -85.28% | 2.0M N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -278.7M +60.17% | -174.0M +13.99% | -152.6M +12.36% | -135.8M +4.12% | |
Net Income from Continuing Operations Applicable to Common | -278.4M +61.88% | -172.0M +12.67% | -152.6M +12.36% | -135.8M +4.12% | |
Basic EPS and Net Income | -3.18 +57.43% | -2.02 -2.88% | -2.08 +2.46% | -2.03 +3.05% | |
Diluted EPS and Net Income | -3.18 +57.43% | -2.02 -2.88% | -2.08 +2.46% | -2.03 +3.05% | |
Basic Weighted Average Shares | 87.7M +1.76% | 86.2M +17.66% | 73.2M +9.31% | 67.0M +0.96% | |
Diluted Weighted Average Shares | 87.7M +1.76% | 86.2M +17.66% | 73.2M +9.31% | 67.0M +0.96% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 149.1M -33.57% | 224.5M +501.48% | 37.3M -27.96% | 51.8M -42.87% | |
Short-Term Investments | 518.1M +3.02% | 502.9M +30.08% | 386.6M +0.12% | 386.2M -9.62% | |
Cash and Cash Equivalents and Short-Term Investments | 667.2M -8.27% | 727.4M +71.57% | 424.0M -3.20% | 438.0M -15.44% | |
Total Current Assets | 708.7M -4.86% | 744.8M +72.22% | 432.5M -3.12% | 446.4M -14.53% | |
Accumulated Depreciation | 2.9M -11.45% | 3.3M +33.56% | 2.5M +52.96% | 1.6M +89.93% | |
Property and Plant and Equipment and Net | 7.9M +367.00% | 1.7M -9.52% | 1.9M -26.81% | 2.5M -4.98% | |
Total Long-Term Assets | 14.5M +85.38% | 7.8M +3.20% | 7.6M +131.20% | 3.3M -0.54% | |
Total Assets | 738.4M -2.87% | 760.2M +69.32% | 448.9M -1.62% | 456.3M -14.56% | |
Income Taxes Payable | 239,000 -88.40% | 2.1M N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 0 -100.00% | 2.6M N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 117.0M +48.61% | 78.7M +123.21% | 35.3M +46.58% | 24.1M +7.13% | |
Total Long-Term Debt | 9.7M +40.41% | 6.9M -25.89% | 9.3M +1.90% | 9.2M +115.48% | |
Total Long-Term Liabilities | 3.2M +76.32% | 1.8M +154.61% | 705,000 +166.04% | 265,000 -29.33% | |
Total Liabilities | 564.2M +62.83% | 346.5M +570.74% | 51.7M +43.39% | 36.0M +31.29% | |
Retained Earnings | -1.2B +31.12% | -895.4M +24.12% | -721.4M +26.83% | -568.8M +31.37% | |
Total Stockholders Equity | 174.1M -57.90% | 413.6M +4.12% | 397.3M -5.47% | 420.3M -17.04% | |
Total Shares Outstanding | 87.9M +12.30% | 78.2M +5.22% | 74.3M +8.84% | 68.3M +2.62% | |
Cash Flow | |||||
Cash from Operating Activities | -64.1M -147.69% | 134.3M +207.61% | -124.8M +13.41% | -110.1M +5.27% | |
Capital Expenditures | 6.6M +1,306.36% | 472,000 +180.95% | 168,000 -73.16% | 626,000 -45.42% | |
Cash from Investing Activities | -13.1M -87.11% | -101.6M -753.02% | 15.6M -52.32% | 32.6M +125.72% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 1.8M -98.84% | 154.4M +62.92% | 94.8M +145.77% | 38.6M +1,222.71% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -14,241.60% +3,872.05% | -358.55% N/A | N/A N/A | N/A N/A | |
Return on Assets | -37.19% +29.23% | -28.78% -14.66% | -33.72% +22.93% | -27.43% +24.19% | |
Return on Equity | -94.82% +120.97% | -42.91% +14.92% | -37.34% +27.39% | -29.31% +25.53% | |
Revenue Growth | -96.04% N/A | N/A N/A | N/A N/A | N/A N/A | |
Current Ratio | 6.06 -35.98% | 9.46 -22.84% | 12.26 -33.91% | 18.56 -20.22% | |
Cash Ratio | 1.27 -55.30% | 2.85 +169.46% | 1.06 -50.85% | 2.15 -46.67% | |
Debt-to-Equity Ratio | 0.06 +142.61% | 0.02 N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.01 +5.60% | 0.01 N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow